- Corporate Officers - P
- Pakianathan Deepika
Insider Trading History of Pakianathan Deepika
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pakianathan Deepika since 2006.
This trader's CIK number is 1270734.
At the time of last reporting, Pakianathan Deepika was the Officer of Mereo Biopharma Group Plc. (stock ticker symbol MREO).
Also see all insider trading activities at Mereo Biopharma Group Plc.
Note that in the past
PAKIANATHAN DEEPIKA also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Trivascular Technologies, Inc. (TRIV) by Pakianathan Deepika
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | TRIV | 833,333 | $9,999,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Karyopharm Therapeutics Inc. (KPTI) by Pakianathan Deepika
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | KPTI | 0 | $0 | 1,724,222 | $1,665,791 | 0 | $0 |
| 2022 | KPTI | 0 | $0 | 538,784 | $3,434,742 | 0 | $0 |
| 2015 | KPTI | 45,454 | $1,499,982 | 0 | $0 | 0 | $0 |
| 2014 | KPTI | 114,419 | $2,995,458 | 0 | $0 | 0 | $0 |
| 2013 | KPTI | 312,500 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alexza Pharmaceuticals Inc. (ALXA) by Pakianathan Deepika
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | ALXA | 1,000 | $8,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mereo Biopharma Group Plc (MREO) by Pakianathan Deepika
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | MREO | 0 | $0 | 105,244 | $466,230 | 105,244 | $239,956 |
Yearly summary of insider trading at Oncomed Pharmaceuticals Inc (OMED) by Pakianathan Deepika
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | OMED | 80,203 | $1,521,849 | 0 | $0 | 0 | $0 |
| 2013 | OMED | 382,353 | $6,500,001 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Calithera Biosciences, Inc. (CALA) by Pakianathan Deepika
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CALA | 0 | $0 | 121,333 | $46,834 | 0 | $0 |
| 2014 | CALA | 1,000,000 | $10,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alder Biopharmaceuticals Inc (ALDR) by Pakianathan Deepika
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | ALDR | 350,000 | $3,500,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Pakianathan Deepika:
1. Trivascular Technologies, Inc. (TRIV)
2. Karyopharm Therapeutics Inc. (KPTI)
3. Alexza Pharmaceuticals Inc. (ALXA)
4. Mereo Biopharma Group Plc (MREO)
5. Oncomed Pharmaceuticals Inc (OMED)
6. Calithera Biosciences, Inc. (CALA)
7. Alder Biopharmaceuticals Inc (ALDR)
Table 1. Insider trading of Trivascular Technologies, Inc. (TRIV) by Pakianathan Deepika
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-04-22 | TRIV | Buy | 833,333 | 12.00 | 9,999,996 |
Table 2. Insider trading of Karyopharm Therapeutics Inc. (KPTI) by Pakianathan Deepika
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-05 | KPTI | Sale | 468,044 | .96 | 448,386 |
| 2024-06-06 | KPTI | Sale | 118,452 | .98 | 116,438 |
| 2024-06-07 | KPTI | Sale | 231,548 | .95 | 220,202 |
| 2024-06-04 | KPTI | Sale | 341,040 | .95 | 324,670 |
| 2024-06-03 | KPTI | Sale | 360,744 | 1.00 | 361,104 |
| 2024-05-31 | KPTI | Sale | 204,394 | .95 | 194,991 |
| 2022-06-08 | KPTI | Sale | 325,977 | 6.50 | 2,119,828 |
| 2022-06-09 | KPTI | Sale | 211,500 | 6.18 | 1,307,070 |
| 2022-06-10 | KPTI | Sale | 1,307 | 6.00 | 7,844 |
| 2015-01-12 | KPTI | Buy | 45,454 | 33.00 | 1,499,982 |
| 2014-05-23 | KPTI | Buy | 1,769 | 26.45 | 46,784 |
| 2014-05-22 | KPTI | Buy | 20,000 | 26.09 | 521,800 |
| 2014-05-21 | KPTI | Buy | 92,650 | 26.19 | 2,426,874 |
| 2013-11-12 | KPTI | Buy | 312,500 | 16.00 | 5,000,000 |
Table 3. Insider trading of Alexza Pharmaceuticals Inc. (ALXA) by Pakianathan Deepika
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-03-08 | ALXA | Buy | 1,000 | 8.00 | 8,000 |
Table 4. Insider trading of Mereo Biopharma Group Plc (MREO) by Pakianathan Deepika
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-08-22 | MREO | Option Ex | 105,244 | 2.28 | 239,956 |
| 2024-08-22 | MREO | Sale | 105,244 | 4.43 | 466,230 |
Table 5. Insider trading of Oncomed Pharmaceuticals Inc (OMED) by Pakianathan Deepika
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-08-19 | OMED | Buy | 12,541 | 18.89 | 236,886 |
| 2014-08-20 | OMED | Buy | 46,059 | 19.00 | 874,982 |
| 2014-08-21 | OMED | Buy | 21,603 | 18.98 | 409,981 |
| 2013-07-23 | OMED | Buy | 382,353 | 17.00 | 6,500,001 |
Table 6. Insider trading of Calithera Biosciences, Inc. (CALA) by Pakianathan Deepika
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-01-27 | CALA | Sale | 121,333 | .39 | 46,834 |
| 2014-10-07 | CALA | Buy | 500,000 | 10.00 | 5,000,000 |
| 2014-10-07 | CALA | Buy | 500,000 | 10.00 | 5,000,000 |
Table 7. Insider trading of Alder Biopharmaceuticals Inc (ALDR) by Pakianathan Deepika
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-05-13 | ALDR | Buy | 350,000 | 10.00 | 3,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pakianathan Deepika
(Officer of Mereo Biopharma Group Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.